Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Sponsor: Kardigan, Inc.
Summary
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Official title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Two-Part Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2026-06-23
Completion Date
2027-02
Last Updated
2026-07-01
Healthy Volunteers
No
Interventions
Tonlamarsen
Tonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Placebo
Placebo will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Locations (8)
Western Nephrology and Metabolic Bone Disease, PC - Arvada
Arvada, Colorado, United States
Homestead Associates in Research
Homestead, Florida, United States
Progressive Medical Research
Port Orange, Florida, United States
Richmond University Medical Center (RUMC)
Staten Island, New York, United States
Research Innovations, LLC
Beavercreek, Ohio, United States
Chattanooga Research & Medicine CHARM
Chattanooga, Tennessee, United States
Laguna Clinical Research Associates
Laredo, Texas, United States
Baylor Scott and White Research Institute - Temple
Temple, Texas, United States